Preclinical models for prediction of immunotherapy outcomes and immune evasion mechanisms in genetically heterogeneous multiple myeloma.
2023 Mar
Large T cell clones expressing immune checkpoints increase during multiple myeloma evolution and predict treatment resistance.
2023 Sep 20
Endogenous Retroelement Activation by Epigenetic Therapy Reverses the Warburg Effect and Elicits Mitochondrial-Mediated Cancer Cell Death.
2022 Jan 21
Round Table Discussion on Optimal Clinical Trial Design in Precursor Multiple Myeloma.
2024 May 1
The alternative RelB NF-κB subunit is a novel critical player in diffuse large B-cell lymphoma.
2022 Jan 20
Deep MRD profiling defines outcome and unveils different modes of treatment resistance in standard- and high-risk myeloma.
2021 Jan 7
PD-1/PD-L1 immune checkpoint and p53 loss facilitate tumor progression in activated B-cell diffuse large B-cell lymphomas.
2019 May 30
Homeobox NKX2-3 promotes marginal-zone lymphomagenesis by activating B-cell receptor signalling and shaping lymphocyte dynamics.
2016 Jun 14
Acquired mutations in BCL2 family proteins conferring resistance to the BH3 mimetic ABT-199 in lymphoma.
2014 Jun 26
Downregulation of FOXP1 is required during germinal center B-cell function
Sagardoy A, Martinez-Ferrandis JI, Roa S, Bunting KL, Aznar MA, Elemento O, Shaknovich R, Fontán L, Fresquet V, Perez-Roger I, Robles EF, De Smedt L, Sagaert X, Melnick A, Martinez-Climent JA. Blood. 2013 May 23;121(21):4311-20.